Let’s start up with the current stock price of Seelos Therapeutics Inc. (SEEL), which is $1.45 to be very precise. The Stock rose vividly during the last session to $1.54 after opening rate of $1.53 while the lowest price it went was recorded $1.45 before closing at $1.46.Recently in News on December 21, 2021, Seelos Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4). Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, announced today that it has granted a stock option to purchase 75,000 shares of common stock to one new employee. The stock option was granted pursuant to the Seelos Therapeutics, Inc. 2019 Inducement Plan and granted as an inducement material to the new employee entering into employment with Seelos in accordance with Nasdaq Listing Rule 5635(c)(4). You can read further details here
Seelos Therapeutics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.7300 on 01/03/22, with the lowest value was $1.4000 for the same time period, recorded on 01/13/22.
Seelos Therapeutics Inc. (SEEL) full year performance was 0.69%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Seelos Therapeutics Inc. shares are logging -78.11% during the 52-week period from high price, and 6.25% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.36 and $6.60.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 661216 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Seelos Therapeutics Inc. (SEEL) recorded performance in the market was -10.43%, having the revenues showcasing -38.14% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 150.47M, as it employees total of 15 workers.
Analysts verdict on Seelos Therapeutics Inc. (SEEL)
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.9913, with a change in the price was noted -0.55. In a similar fashion, Seelos Therapeutics Inc. posted a movement of -27.66% for the period of last 100 days, recording 3,407,273 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for SEEL is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Seelos Therapeutics Inc. (SEEL): Technical Analysis
Raw Stochastic average of Seelos Therapeutics Inc. in the period of last 50 days is set at 2.72%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 6.10%. In the last 20 days, the company’s Stochastic %K was 15.04% and its Stochastic %D was recorded 16.98%.
Let’s take a glance in the erstwhile performances of Seelos Therapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -10.43%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -40.16%, alongside a boost of 0.69% for the period of the last 12 months. The shares increased approximately by -6.41% in the 7-day charts and went up by -14.12% in the period of the last 30 days. Common stock shares were lifted by -38.14% during last recorded quarter.